Impax Laboratories LLC filed a lawsuit against Dr. Reddy’s Laboratories Ltd. and its American unit to stop the sale of a generic medication for Parkinson’s disease.
They observed that removing GUCY2C from gut cells in mice increased the expression of PD-related genes, prompting them to investigate its role in the brain.